Citation Information :
Hazazi MA, Mashi MH, Sumayli HA, Mobarki AY, Sultan A, Hadi MS, Abulqasim HM, Thubab BM, Patil S. COVID-19 and Periodontitis: A Reality to Live with. J Contemp Dent Pract 2020; 21 (12):1398-1403.
Background: Coronavirus disease-19 (COVID-19) is a recent pandemic that is advancing at a rapid rate. The future course of the disease includes severe respiratory infection and also leads to death if unattended. Meticulous measures are necessary before attending any patient. The dental operatories and the clinic surroundings must be well sanitized so as to prevent the spread of pandemic. Aim and objective: This review discusses in brief about the pathophysiology and course of COVID-19. Further, we discussed in detail the management aspects of patients in periodontal perspective and the sanitization procedures required for the dental clinic. Review results: The SARS coronavirus enters the human circulation via the angiotensin-converting enzyme (ACE) receptors which are also found on the oral mucosal surfaces. Furin and Cathepsin L are the pro-inflammatory molecules released during pathogenesis of periodontitis and mediate the molecular pathways that help the virus invade into the host. The clinic set-up should be modified to best suit the pandemic conditions. This includes the three phases, i.e., phase I: preparatory phase; phase II: implementation phase; and phase III: follow-up. The patient management is explained based on the emergency needs of the patient based on the recent AAP classification of periodontal diseases and conditions 2017 as emergency, urgent, and elective treatment needs which have been explained in detail. Conclusion: It can be strongly concluded that there is direct relationship between oral health and systemic health. The treatment procedures and sanitization protocols must be definitely modified. Further consensus and systematic reviews help us arriving at a more standardized protocol. Clinical significance: This review would help clinicians modify the way they treat patients in the clinic and provide better services depending upon the emergency needs of the patient.
WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 2020, March 11 [Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
Medical Microbiology. 4th ed., University of Texas Medical Branch at Galveston; 1996.
A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727–733. DOI: 10.1056/NEJMoa2001017.
Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center 2020, March 26 [Available from: https://www.medrxiv.org/content/10.1101/2020.03.23.20039446v2.full.pdf.
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China 2020, February 7 [Available from: https://jamanetwork.com/journals/jama/fullarticle/2761044.
CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics 2020;10(12):5613–5622. DOI: 10.7150/thno.45985.
The oral microbiome - an update for oral healthcare professionals. Br Dent J 2016;221(10):657–666. DOI: 10.1038/sj.bdj.2016.865.
A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579(7798):270–273. DOI: 10.1038/s41586-020-2012-7.
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020;12(1):8. DOI: 10.1038/s41368-020-0074-x.
Plasma and crevicular fluid osteopontin levels in periodontal health and disease. J Periodontal Res 2007;42(5):450–455. DOI: 10.1111/j.1600-0765.2007.00968.x.
Expression of proteolytic cathepsins B, D, and L in periodontal gingival fibroblasts and tissues. Lab Invest 1995;73:205–212.
IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts. J Cell Physiol 2008;217(2):423–432. DOI: 10.1002/jcp.21517.
Bacterial and viral pathogens in saliva: Disease relationship and infectious risk. Periodontol 2000 2011;55(1):48–69. DOI: 10.1111/j.1600-0757.2010.00361.x.
Saliva is a non-negligible factor in the spread of COVID-19. Mol Oral Microbiol 2020;35(4):141–145. DOI: 10.1111/omi.12289.
Periodontal medicine. BC Decker Hamilton, ON and London; 2000.
Periodontitis and respiratory diseases: ahat does the recent evidence point to? Current Oral Health Rep 2018;5:63–69.
The periodontopathic bacterium Fusobacterium nucleatum induced proinflammatory cytokine production by human respiratory epithelial cell lines and in the lower respiratory organs in mice. Cell Physiol Biochem 2019;53(1):49–61. DOI: 10.33594/000000120.
Oral health and mortality risk from pneumonia in the elderly. J Dent Res 2008;87(4):334–339. DOI: 10.1177/154405910808700418.
The association between oral microorganisms and aspiration pneumonia in the institutionalized elderly: Review and recommendations. Dysphagia 2010;25(4):307–322. DOI: 10.1007/s00455-010-9298-9.
Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? Br Dent J 2020;228(12):971–975. DOI: 10.1038/s41415-020-1747-8.
Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression. Infect Immun 2014;82(2):587–593. DOI: 10.1128/IAI.00943-13.
Neutrophil extracellular traps in periodontitis: a web of intrigue. J Dent Res 2016;95(1):26–34. DOI: 10.1177/0022034515609097.
The role of neutrophil extracellular traps in COVID-19: only an hypothesis or a potential new field of research? Thromb Res 2020;191:26–27. DOI: 10.1016/j.thromres.2020.04.031.
TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor fedratinib. J Microbiol Immunol Infect 2020;53(3):368–370. DOI: 10.1016/j.jmii.2020.03.005.
The intriguing commonality of NETosis between COVID-19 & periodontal disease. Med Hypotheses 2020;144:109968. DOI: 10.1016/j.mehy.2020.109968.
Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020;34(5):e212–e213. DOI: 10.1111/jdv.16387.
Guidelines for dental care provision during the COVID-19 pandemic. Saudi Dent J 2020;32(4):181–186. DOI: 10.1016/j.sdentj.2020.04.001.
Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol 2018;89:S159–S172. DOI: 10.1002/JPER.18-0006.
Promoting behavioural changes to improve oral hygiene in patients with periodontal diseases: a systematic review. J Clin Periodontol 2020;47(Suppl 22):72–89. DOI: 10.1111/jcpe.13234.
Impact of risk factor control interventions for smoking cessation and promotion of healthy lifestyles in patients with periodontitis: a systematic review. J Clin Periodontol 2020;47(Suppl 22):90–106. DOI: 10.1111/jcpe.13240.
Subgingival instrumentation for treatment of periodontitis. A systematic review. J Clin Periodontol 2020;47(Suppl 22):155–175. DOI: 10.1111/jcpe.13245.
Adjunctive laser or antimicrobial photodynamic therapy to non-surgical mechanical instrumentation in patients with untreated periodontitis: a systematic review and meta-analysis. J Clin Periodontol 2020;47(Suppl 22):176–198. DOI: 10.1111/jcpe.13236.
Efficacy of access flap procedures compared to subgingival debridement in the treatment of periodontitis. A systematic review and meta-analysis. J Clin Periodontol 2020;47(Suppl 22):282–302. DOI: 10.1111/jcpe.13259.
Regenerative surgery versus access flap for the treatment of intra-bony periodontal defects: a systematic review and meta-analysis. J Clin Periodontol 2020;47(Suppl 22):320–351. DOI: 10.1111/jcpe.13237.
Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21(6):533–551. DOI: 10.3109/00016356309011240.